Tamura, Y.; Yamane, K.; Kawano, Y.; Bullinger, L.; Wirtz, T.; Weber, T.; Sander, S.; Ohki, S.; Kitajima, Y.; Okada, S.;
et al. Concomitant Cytotoxic Effector Differentiation of CD4+ and CD8+ T Cells in Response to EBV-Infected B Cells. Cancers 2022, 14, 4118.
https://doi.org/10.3390/cancers14174118
AMA Style
Tamura Y, Yamane K, Kawano Y, Bullinger L, Wirtz T, Weber T, Sander S, Ohki S, Kitajima Y, Okada S,
et al. Concomitant Cytotoxic Effector Differentiation of CD4+ and CD8+ T Cells in Response to EBV-Infected B Cells. Cancers. 2022; 14(17):4118.
https://doi.org/10.3390/cancers14174118
Chicago/Turabian Style
Tamura, Yumi, Keita Yamane, Yohei Kawano, Lars Bullinger, Tristan Wirtz, Timm Weber, Sandrine Sander, Shun Ohki, Yasuo Kitajima, Satoshi Okada,
and et al. 2022. "Concomitant Cytotoxic Effector Differentiation of CD4+ and CD8+ T Cells in Response to EBV-Infected B Cells" Cancers 14, no. 17: 4118.
https://doi.org/10.3390/cancers14174118
APA Style
Tamura, Y., Yamane, K., Kawano, Y., Bullinger, L., Wirtz, T., Weber, T., Sander, S., Ohki, S., Kitajima, Y., Okada, S., Rajewsky, K., & Yasuda, T.
(2022). Concomitant Cytotoxic Effector Differentiation of CD4+ and CD8+ T Cells in Response to EBV-Infected B Cells. Cancers, 14(17), 4118.
https://doi.org/10.3390/cancers14174118